Neuroleptic malignant syndrome possibly caused by molindone hydrochloride

J. D. Gradon

    Research output: Contribution to journalArticlepeer-review


    The case of a patient who develod neuroleptic malignant syndrome (NMS) on three separate occasions is presented. Her third bout of this syndrome possibly was caused by molindone hydrochloride. This medication has been reported only once previously to cause NMS. The pharmacology of molindone is reviewed and a complicating factor in this case - the recent onset of hypothyroidism - is discussed together with its implication in the development of the clinical manifestations of this syndrome.

    Original languageEnglish (US)
    Pages (from-to)1071-1072
    Number of pages2
    JournalDICP, Annals of Pharmacotherapy
    Issue number10
    StatePublished - Jan 1 1991

    ASJC Scopus subject areas

    • Pharmacology, Toxicology and Pharmaceutics(all)
    • Pharmacology (medical)

    Fingerprint Dive into the research topics of 'Neuroleptic malignant syndrome possibly caused by molindone hydrochloride'. Together they form a unique fingerprint.

    Cite this